Max Robotics — Global Service Robot Directory + US Certification

About

Ailsa McLean is a leading cardiac electrophysiologist whose research has fundamentally advanced the treatment of atrial fibrillation (AF), particularly through the integration of robotic and contact force sensing technologies. Her landmark work includes the first international multicenter registry comparing robotic versus manual ablation for persistent AF, demonstrating that remote robotic navigation can achieve comparable efficacy while potentially enhancing procedural precision. In a randomized trial, she further validated these findings, establishing robotic ablation as a viable alternative to conventional manual techniques. McLean’s investigations into steerable sheaths revealed their critical role in improving catheter contact force consistency, directly reducing the incidence of pulmonary vein reconnection—a major cause of AF recurrence. Her studies, collectively cited over 80 times, have shaped contemporary ablation protocols by emphasizing the importance of real-time force monitoring and advanced catheter navigation. Beyond her clinical trials, McLean’s contributions have been recognized through invitations to present at international electrophysiology conferences and her role in developing best-practice guidelines for persistent AF management. Her work continues to influence how clinicians optimize lesion formation and procedural outcomes, making her a pivotal figure in the evolution of catheter ablation for complex arrhythmias.